Sfoglia per Autore
Mostrati risultati da 1 a 6 di 6
Isothiocyanates as potentials alzheimer's disease-modifying drugs.
2009 BOLONDI C.; A. TAROZZI; F. MORRONI; A. MERLICCO; G. CANTELLI FORTI; P. HRELIA
Neuroprotective effects of cyanidin 3-O-glucopyranoside on amyloid beta (25-35) oligomer-induced toxicity.
2010 Tarozzi A; Morroni F; Merlicco A; Bolondi C; Teti G; Falconi M; Cantelli-Forti G; Hrelia P.
Guanosine protects human neuroblastoma cells from oxidative stress and toxicity induced by Amyloid-beta peptide oligomers.
2010 Tarozzi A.; Merlicco A.; Morroni F.; Bolondi C.; Di Iorio P.; Ciccarelli R.; Romano S.; Giuliani P.; Hrelia P.
Neuroprotective effects of erucin against 6-hydroxydopamine-induced oxidative damage in a dopaminergic-like neuroblastoma cell line.
2012 TAROZZI A.; F. MORRONI; C. BOLONDI; G. SITA; P. HRELIA; A. DJEMIL; G. CANTELLI FORTI
Neuroprotective effect of sulforaphane in 6-hydroxydopamine-lesioned mouse model of Parkinson's disease
2013 Morroni F.; Tarozzi A.; Sita G.; Bolondi C.; Zolezzi Moraga JM; Cantelli-Forti G.; Hrelia P.
From the dual function lead AP2238 to AP2469, a multi-target-directed ligand for the treatment of Alzheimer’s disease
2014 Tarozzi A.; Bartolini M.; Piazzi L.; Valgimigli L.; Amorati R.; Bolondi C.; Djemil A.; Mancini F.; Andrisano V.; Rampa A.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Isothiocyanates as potentials alzheimer's disease-modifying drugs. | BOLONDI C.; A. TAROZZI; F. MORRONI; A. MERLICCO; G. CANTELLI FORTI; P. HRELIA | 2009-01-01 | - | Società Italiana di Farmacologia | 4.02 Riassunto (Abstract) | - |
| Neuroprotective effects of cyanidin 3-O-glucopyranoside on amyloid beta (25-35) oligomer-induced toxicity. | Tarozzi A; Morroni F; Merlicco A; Bolondi C; Teti G; Falconi M; Cantelli-Forti G; Hrelia P. | 2010-01-01 | NEUROSCIENCE LETTERS | - | 1.01 Articolo in rivista | - |
| Guanosine protects human neuroblastoma cells from oxidative stress and toxicity induced by Amyloid-beta peptide oligomers. | Tarozzi A.; Merlicco A.; Morroni F.; Bolondi C.; Di Iorio P.; Ciccarelli R.; Romano S.; Giuliani ...P.; Hrelia P. | 2010-01-01 | JOURNAL OF BIOLOGICAL REGULATORS & HOMEOSTATIC AGENTS | - | 1.01 Articolo in rivista | - |
| Neuroprotective effects of erucin against 6-hydroxydopamine-induced oxidative damage in a dopaminergic-like neuroblastoma cell line. | TAROZZI A.; F. MORRONI; C. BOLONDI; G. SITA; P. HRELIA; A. DJEMIL; G. CANTELLI FORTI | 2012-01-01 | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - | 1.01 Articolo in rivista | ijms-13-10899-v2.pdf |
| Neuroprotective effect of sulforaphane in 6-hydroxydopamine-lesioned mouse model of Parkinson's disease |
Morroni F.; Tarozzi A.; Sita G.; Bolondi C.; Zolezzi Moraga JM; Cantelli-Forti G.; Hrelia P. |
2013-01-01 | NEUROTOXICOLOGY | - | 1.01 Articolo in rivista | - |
| From the dual function lead AP2238 to AP2469, a multi-target-directed ligand for the treatment of Alzheimer’s disease | Tarozzi A.; Bartolini M.; Piazzi L.; Valgimigli L.; Amorati R.; Bolondi C.; Djemil A.; Mancini F....; Andrisano V.; Rampa A. | 2014-01-01 | PHARMACOLOGY RESEARCH & PERSPECTIVES | - | 1.01 Articolo in rivista | prp20002-e00023.pdf |
Mostrati risultati da 1 a 6 di 6
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile